Literature DB >> 7780653

Haemostatic mechanism in the endometrium: role of cyclo-oxygenase products and coagulation factors.

T J Gelety1, G Chaudhuri.   

Abstract

1. The primary mechanism of haemostasis in the endometrium of rat was studied and results were compared to that in the mesenteric artery. 2. The bleeding time of the rat endometrium as assessed by haemoglobin output was significantly decreased after pretreatment of the animals with either indomethacin (5 mg kg-1, i.v.) or meclofenamate (3 mg kg-1, i.v.) whereas the bleeding time was significantly increased in the rat mesenteric artery. 3. The bleeding time of the rat endometrium was unchanged from control values following treatment with prostacyclin (0.5 microgram kg-1 min-1, i.v.) or 1-benzylimidazole (50 mg kg-1, i.v.) whereas the bleeding times were increased in the rat mesentric artery. 4. Administration of heparin (100 units kg-1) increased the bleeding time in the rat mesenteric artery but had no effect on the bleeding time of the endometrium. 5. Superfusion of the endometrium with 16, 16-dimethyl PGE2 (1 microgram ml-1) a vasodilator, increased the bleeding time of the endometrium but superfusion of PGE2 over the mesenteric artery did not affect the bleeding time from this site. 6. Histological studies of the mesenteric artery and the endometrium following haemostatis revealed that the haemostatic plug in the mesenteric artery was mainly composed of platelets and fibrin whereas in the endometrium it was mainly composed of fibrin. 7. These findings suggest that haemostasis in the endometrium may be mediated by the vascular tone and fibrin whereas formation of the platelet plug may be primary mechanism for haemostasis in the mesenteric artery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780653      PMCID: PMC1510305          DOI: 10.1111/j.1476-5381.1995.tb13300.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

Review 1.  The hemostatic plug.

Authors:  J J Sixma; J Wester
Journal:  Semin Hematol       Date:  1977-07       Impact factor: 3.851

2.  Plasminogen activators in the endometrium. I. Methodological aspects.

Authors:  G Rybo
Journal:  Acta Obstet Gynecol Scand       Date:  1966       Impact factor: 3.636

3.  Effect of intrauterine contraceptive device on uterine haemostasis: a morphological study.

Authors:  S R Aparicio; K Bradbury; C C Bird; M E Foley; D M Jenkins; J K Clayton; J S Scott; S M Rajah; G P McNicol
Journal:  Br J Obstet Gynaecol       Date:  1979-04

4.  Effects of anti-inflammatory drugs on prostaglandin biosynthesis.

Authors:  R Flower; R Gryglewski; K Herbaczyńska-Cedro; J R Vane
Journal:  Nat New Biol       Date:  1972-07-26

5.  Aspirin selectively inhibits prostaglandin production in human platelets.

Authors:  J B Smith; A L Willis
Journal:  Nat New Biol       Date:  1971-06-23

Review 6.  Pharmacological interactions between prostacyclin and thromboxanes.

Authors:  B J Whittle; S Moncada
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

7.  Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa.

Authors:  B J Whittle; G A Higgs; K E Eakins; S Moncada; J R Vane
Journal:  Nature       Date:  1980-03-20       Impact factor: 49.962

8.  Prostaglandin E and F concentrations in human endometrium after insertion of intrauterine contraceptive device.

Authors:  K Hillier; J M Kasonde
Journal:  Lancet       Date:  1976-01-03       Impact factor: 79.321

9.  Endometrial prostaglandins in women with abnormal menstrual bleeding.

Authors:  I T Cameron; R Leask; R W Kelly; D T Baird
Journal:  Prostaglandins Leukot Med       Date:  1987-10

10.  Uterine and peripheral blood concentrations of vasodilator prostaglandins in conscious pregnant rabbits.

Authors:  G Chaudhuri; P Barone; E Lianos; M Hurd; A Lele; R Venuto
Journal:  Am J Obstet Gynecol       Date:  1982-12-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.